,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1209278,1,2,,312466421,442478,Active,308153612.0,1548.0,4.5,Kd,Binding affinity to CYP2A6 (unknown origin) assessed as type 1 interaction as increase in absorbance 379 to 387 nm and decrease in 414 to 420 nm,Confirmatory,22696418,
1,1209280,1,1,,312466421,442478,Unspecified,,,,,Ratio of Kd for CYP2A6 (unknown origin) to Kd for CYP2A13 assessed as type 1 interaction as increase in absorbance 379 to 387 nm and decrease in 414 to 420 nm,Other,22696418,
2,1209283,1,2,,312466421,442478,Unspecified,77416854.0,1553.0,54.0,Ki,Mixed inhibition of CYP2A13 (unknown origin),Confirmatory,22696418,
3,1209284,1,2,,312466421,442478,Active,308153612.0,1548.0,2.0,Ki,Mixed inhibition of CYP2A6 (unknown origin),Confirmatory,22696418,
4,1209285,1,1,,312466421,442478,Unspecified,,,,,Ratio of Ki for CYP2A6 (unknown origin) to Ki for CYP2A13 (unknown origin),Other,22696418,
5,1209287,1,2,,312466421,442478,Active,77416854.0,1553.0,0.58,Kd,Binding affinity to CYP2A13 (unknown origin) assessed as type 1 interaction as increase in absorbance 379 to 387 nm and decrease in 414 to 420 nm,Confirmatory,22696418,
